Huikai Li

6PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 17, 2026
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis.

Yang Liu, Dandan Wu, Xing Li

|Jan 16, 2026
Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors.

Mei Feng, Hong Liu, Lu Zheng

|Oct 16, 2025
Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial.

Huikai Li, Tongguo Si, Rentao Li

|Sep 22, 2025
Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Xiuchao Wang, Hongwei Wang, Meng Zhang

|Aug 12, 2022
Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models.

Huikai Li, Han Mu, Yajie Xiao

|Aug 02, 2021
Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway.

Jianwen Hao, Qizhen Peng, Keruo Wang

Pageof 1

Frequent Collaborators

3 joint publications

Yang Liu

2 joint publications

Jihui Hao

2 joint publications

Chuntao Gao

1 joint publications

Jianwen Hao